Board

​Gill Eapen, MS, MBA, CFA

Over three decades of experience in finance, economics, planning and management. Previous employers include Pfizer, HP, Deloitte, and ABB. Consulting clients in various industries including life-sciences, hi-technology, aerospace, manufacturing, financial services & healthcare.
MBA, University of Chicago
MS, Northwestern University
B. Tech, Indian Institute of Technology
​CFA Charter holder.

Craig Saxton, MD, PhD

Over 3 decades of experience in guiding large scale Research and Development. Retired Executive Vice President, Pfizer. Member of the board of directors of Tularik , Neurogen and Veritas Medicine. Graduated in medicine from the University of Leeds in 1965. Pursued research in Cardiovascular disease and applied physiology from 1966 until joining Pfizer in 1976.

​

Advisory Board

Mr. David Kallus, MBA, MS 
A Chief Investment Officer, he is a veteran of sovereign wealth funds,  global macro hedge funds, and asset backed securitization vehicles. In recent years, he has also been a pioneer in structured credit origination. He is a  graduate of University of Chicago with an MBA finance, and of Columbia University's International Affairs program where he has a Masters. He is a graduate of Columbia college.

Dr. Pierre Etienne, MD
Over 2 decades of experience in early clinical research and development operations. Previous employers include CIBA-Geigy (Novartis), Pfizer, PhageTech and Targanta Therapeutics (TARG) where he served first as CEO from June 2003 to September 2006 and Chief Development Officer until December 2008. Graduated in medicine from Université de Liège (Belgium) in 1972. Pursued research in Alzheimer’s disease at McGill University from 1976 until joining CIBA-Geigy in 1983.

Dr. Ian Williams, PhD
Over 2 decades of R&D experience in Pharma culminating in heading a large research department for 4 years. 6 years experience in global strategic planning for Pfizer with an emphasis in ethics, future scenarios, and assessment of R&D performance. Board member of Vion Pharmaceuticals. Pittsburgh, PA. Research fellow at Rockefeller, D. Phil.– the University of Oxford, B. Sc.-University of Bristol.

Dr. David Dresback, PhD
Over 27 years of experience in developing and managing the development of conventional and novel dosage forms and evaluating and sourcing new drug delivery technology and partners.  Retired Senior Director-Pfizer. B.S Pharmacy and Ph.D. Pharmaceutical Chemistry, University of Michigan.

Dr. Ralph Stevenson, PhD
11 years of experience in academia performing research in the areas of diabetes and osteoporosis followed by 21 years management experience in Research and Development at Pfizer with oversight of diabetes, obesity, and metabolic syndrome. Ph.D. in Pharmacology, Glasgow University.

Mr. Jim Schoeck, MBA, MHS
Over 30 years of experience in healthcare management; 10 years in Hospital/System Administration and 20+years as an entrepreneur in physician practice management.  Jim has been involved in the formation of large primary care-based organizations focused on the effective delivery of care and the assumption of risk.  MBA and Master of Health Sciences from the University of Florida. ​

Mr. Saju Joseph, MBA
Hands-on and versatile leader with 20+ years experience spanning strategy, operations, sales and investing globally in the services industry. with deep expertise Digital/Process/insights led transformation; strategic relationship building and delivering value for F1000 enterprises globally;

Dr. Alan Fine, MD   
Over three decades of experience in private practice of Obstetrics and Gynecology. Currently a Principal Investigator for Shionogi, Inc, and Allergan, Inc.  Consultant for Amgen, Inc and Shionogi, Inc in fields of Osteoporosis and menopausal medicine. Ob/Gyn Pharmacy and Therapeutics board member for Connecticare, Inc.

Mr. James Sylvia
Over 30 years of experience in all facets of retail and real estate development with a concentration in the food/supermarket sector including e commerce. Led strategy and project teams for Ahold USA (Stop & Shop Supermarkets, Giant Food, Peapod home delivery, etc) for 23 years driving 300 projects per year with an annual capex over $1B. Currently consulting across multiple related industries with a focus on disruptive technologies. ​

Ms. Aileen Leventon, MBA, JD
40 Years of experience with leading law firms, alternate legal service providers and corporate legal departments to add value to their clients and firms by harnessing data. MBA from Columbia University, JD from Cornell University, and BA, Phi Beta Kappa from Stony Brook University.​

Mr. Tristan Jordan
Technology company executive with more than 20 years of sales, marketing, product and operational leadership and general management.  Deep experience working with investors and leading rapid growth fueled by product innovation, sales acceleration, new market penetration and mergers and acquisitions.  Currently runs a large division at Community Brands that provides learning management and career center software to thousands of professional associations and corporate clients.